Beta-hydroxybutyrate / Exogenous Ketones for Weight Loss
Verdict: Taiwan Regulatory Restriction
Across 5 PubMed studies, the evidence for Beta-hydroxybutyrate / Exogenous Ketones in Weight Loss grades Tier D — counter-evidence.
D 🔴 D Counter-Evidence Taiwan Regulatory Restriction
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.40
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Taiwan Regulatory Restriction
Confidence
77%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.398
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — D 級條件未達 (需 E1-E3 negative；實際 E6)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (5)L2 · primary research & systematic reviews
14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial
Finding: BHB monoester lowered 24h mean glucose 7.8% (p=0.0001) and improved FMD (p=0.0004); body mass fell ~1.03 kg in BOTH arms with NO between-arm difference, indicating no specific weight-loss effect of BHB beyond placebo.
View on PubMed A Ketone Ester Drink Lowers Human Ghrelin and Appetite (Stubbs et al.)
Finding: Acute KE raised blood BHB to 3.3 mM; ghrelin and hunger reduced ~50% at 1.5-4h vs dextrose (p<0.05). Mechanistic appetite-suppression signal only; no body-weight endpoint.
View on PubMed Effects of Ketone Ester Supplementation on Cognition and Appetite in Individuals with and Without Metabolic Syndrome: A Randomized Trial
Finding: Acute appetite decreased only in non-MetS group (p<=0.048); relative fat intake INCREASED in MetS group post-KE (p=0.002). No chronic body-weight outcome; effect on weight loss not demonstrated and possibly attenuated in MetS.
View on PubMed Relationship between Ketones, Ghrelin, and Appetite on Isocaloric Diets (CARBFUNC)
Finding: All 3 diets produced equivalent weight loss (-5% to -7% at 12 mo) and VAT reduction (-12% to -17%); LCHF ketosis insufficient to suppress ghrelin or confer added weight loss vs HCLF. Indicates mildly raised endogenous BHB does not independently drive weight loss.
View on PubMed Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity (narrative review)
Finding: Review concludes mechanistic rationale exists for muscle preservation during weight loss but no established dosing and 'additional studies are needed' to translate to humans; no human weight-loss efficacy data presented.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4a US FDA
Supportive
FDA has no questions source↗
L4b EU EFSA
Cautious
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Makers of dietary supplements rarely do clinical trials. That's part of the reason why there's little scientific proof to show that weight-loss supplements work. Overall, little proof exists that any dietary supplement can help with healthy, long-term weight loss. source↗
L5c Cleveland Clinic
Cautious
You may think more clearly and notice appetite suppression when taking ketone supplements, but they don't actually help your body burn fat. These supplements don't really offer health benefits. They may actually even cause your body to store fat and increase insulin instead of burning your body fat for fuel. source↗
L5e Specialty Society (condition-mapped)
Against
There is no convincing scientific evidence that taking exogenous ketones (ketones produced outside of your body) has any benefit in causing weight loss or improving other conditions related to a ketogenic diet. source↗